September 2, 2008
Laborie Receives CE Mark and Canadian Medical Device Licence for Tetra™ Bladder Monitor System
VANCOUVER, British Columbia, September 2, 2008 - Urodynamix Technologies Ltd. (TSX-V:URO)
today announced that its worldwide distribution partner, Laborie Medical Technologies Inc. has received CE Mark approval to begin marketing the Tetra Bladder Monitor System in Europe. Laborie was also granted a medical device license to sell Tetra in accordance with Health Canada's medical device regulations.
“CE Mark and Health Canada approvals represent significant progress in the commercialization of Urodynamix’s NIRS technologies,” said Barry Allen, President and CEO of Urodynamix. “We look forward to expanding Tetra’s availability in Europe and Canada with Laborie as our worldwide licensing partner. Following the U.S. launch of Tetra in June 2008, we now have access to 80 percent of the worldwide urodynamics testing market.”
Tetra is a non-invasive diagnostic medical device based on Urodynamix’s near infrared spectroscopy (NIRS) technology. An accessory to Laborie’s premium urodynamics systems, Tetra enables non-invasive testing of bladder activity in patients with lower urinary tract symptoms (LUTS).
About Laborie Medical Technologies
Founded in 1967 by Ray Laborie, Laborie Medical Technologies is the leading global manufacturer of urodynamics equipment used in the diagnosis and treatment of incontinence, BPH, and voiding dysfunction.
As Laborie enters its 41st anniversary in business, it has established itself as ‘the’ supplier of pelvic floor assessment systems in many key academic centers. Laborie’s AQUARIUS Wireless Urodynamic System is considered the benchmark diagnostic device for clinical trials and medical research. Laborie’s product line includes urodynamic diagnostics, biofeedback/stimulation systems, compact ultrasound, computerized and physical bladder modeling tools, EMR solutions, consumables, as well as accredited education.
The network of installed users has afforded Laborie the opportunity to feed this network with new and exciting technology on a continuous basis. Recently, Laborie introduced the world's most compact, high resolution USB ultrasound system (NuWav™), and it intends on providing Tetra™ technology in the same manner. Laborie has offices in Canada, USA, Belgium, China, UK and now Paris, France and San Paulo, Brazil. It has direct sales and distribution networks in 52 countries across North America, Europe, Asia and Oceania.
About Urodynamix Technologies Ltd.
Urodynamix Technologies is a Canadian medical device company developing and commercializing non-invasive medical technology based on proprietary applications of near-infrared spectroscopy (NIRS). The Company is currently focused on products that aid in the diagnosis and treatment of urinary incontinence, lower urinary tract symptoms, prostate cancer, benign prostatic hyperplasia, and traumatic increases in intra-abdominal pressure that cause abdominal compartment syndrome. Urodynamix’s breakthrough medical technology has the potential to beneficially affect more than 200 million people worldwide.
Certain information contained in this press release may be forward-looking and is subject to unknown risks, which could cause actual results to differ materially from those set forth or implied herein. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For more information, please contact:
Craig Pamplin
Director, Corporate Development and Communications
Urodynamix Technologies Ltd.
Tel: (604) 638-0247
Email: cpamplin@urodynamix.com
www.urodynamix.com |
